Pilot Project Program
试点项目计划
基本信息
- 批准号:10505156
- 负责人:
- 金额:$ 53.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-03 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressApplications GrantsAwardBiometryCOVID-19COVID-19 pandemicChronic DiseaseClinicalClinical InvestigatorClinical ResearchCollaborationsCommunitiesCommunity OutreachConsultationsData AnalysesDevelopmentDisciplineDiseaseEarly DiagnosisEnsureExtramural ActivitiesFaceFundingGoalsGrantHealthHealth ServicesHealthcareIACUCIncentivesInstitutionInstitutional Review BoardsInterventionLeadershipMaineMentorsMentorshipNew EnglandNewsletterOpiate AddictionOutcomePhasePhysiciansPilot ProjectsPractice based researchPreventionPrimary Care PhysicianProcessPublic HealthPublicationsResearchResearch DesignResearch PersonnelResearch SupportResourcesRural CommunityRural HealthScientistStudy SectionTechnologyTimeTranslational ResearchTranslationsTribesUniversitiesUrban CommunityWorkanalytical methodbarrier to carebehavioral healthcareercommunity engagementdesigndiversity and equitydiversity and inclusionepidemiology studyexperiencehealth care availabilityhealth care deliveryhealth communicationhealth disparityhealth inequalitiesimprovedinterdisciplinary collaborationinvestigator trainingmeetingspractice-based research networkprogramsprospectivepublic health researchrecruitrural arearural underservedsocial mediasuccesssurvivorshiptranslational scientisttranslational studyunderserved communityweb site
项目摘要
The northern New England region constitutes a unique public health landscape with challenging needs for its
residents, particularly prevention, early detection, and intervention of chronic diseases. The Pilot Projects
Program (PPP) successfully provided support to clinical and translational investigators to conduct public health
research addressing health inequities in urban, rural and underserved communities that face sizable barriers to
healthcare access. The PPP worked with all the NNE-CTR Cores over the first four years to develop and
implement 29 projects with clinical, translational, and Covid-19 implications. Those pilots enhanced healthcare
delivery as well as accelerated the career trajectory of several pilot project awardees. Building upon our
considerable accomplishments, the current aims of the PPP will support a three step process to enhance
further pilot success while simultaneously improving our mentoring program in collaboration with the
Professional Development Core. In Aim 1 of this three-stage process, we will expand researcher recruitment
and support concept development to incentivize and build meaningful interdisciplinary collaborations. We will
disseminate PPP opportunities through our NNE-CTR website, newsletter, and social media, and support
young, early-stage and established investigators during concept development in collaboration with the
Professional Development (PDC) and the Biostatistics, Epidemiology, and Research Design (BERD) Cores. In
Aim 2, we will help investigators prepare Pilot Project applications by providing mentorship in study design and
data analysis, and by engaging navigators from the Community Engagement and Outreach (CEO), PDC, and
BERD Cores. We will encourage consultation with Core leadership, community representatives, and content
experts to enhance design feasibility. In the final stage, Aim 3, we will mentor pilot project awardees during the
post-award phase by providing scientific and professional development guidance to awardees via quarterly
meetings. We will assist awardees to develop extramural grant proposals, including holding mock “study
sections” in partnership with the PDC, to ensure competitive proposals. For those whose external applications
fell below the payline, we will return to the first stage and support further concept development for subsequent
applications. We will also ensure all research conducted through the PPP is continually aligned with principles
of diversity, equity, and inclusion. We will leverage our existing partnerships with CTSAs, State Departments of
Health, the Northern New England Practice-Based Research Network, and the Rural Health Communications
Network. By restructuring our pilot awards, we will support an array of projects, ranging from multistage clinical
and translational studies to community-specific public health initiatives. This should provide pilot awardees
with the opportunity to enhance their academic careers while serving the rapidly shifting public health needs of
our communities.
新英格兰北部地区构成了独特的公共卫生格局,其需求具有挑战性
尤其是慢性病的预防、早期发现和干预。试点项目
计划(PPP)成功为临床和转化研究人员开展公共卫生工作提供支持
研究解决城市、农村和服务不足社区的健康不平等问题,这些社区面临着巨大的障碍
医疗保健服务。 PPP 在前四年与所有 NNE-CTR 核心合作开发和
实施 29 个具有临床、转化和 Covid-19 影响的项目。这些飞行员改善了医疗保健
交付并加速了几位试点项目获奖者的职业轨迹。建立在我们的
PPP 目前的目标将支持三步流程,以加强
进一步试点取得成功,同时与以下机构合作改进我们的指导计划
专业发展核心。在这个三阶段过程的目标 1 中,我们将扩大研究人员招募
支持概念开发,以激励和建立有意义的跨学科合作。我们将
通过我们的 NNE-CTR 网站、时事通讯和社交媒体传播 PPP 机会,并提供支持
在概念开发过程中与年轻、早期和成熟的研究人员合作
专业发展 (PDC) 和生物统计学、流行病学和研究设计 (BERD) 核心。在
目标 2,我们将通过提供研究设计和指导方面的指导来帮助研究人员准备试点项目申请
数据分析,并通过让来自社区参与和外展 (CEO)、PDC 和
BERD 核心。我们将鼓励与核心领导层、社区代表和内容进行协商
专家加强设计可行性。在最后阶段,目标 3,我们将在整个过程中指导试点项目获奖者
获奖后阶段,通过季度为获奖者提供科学和专业的发展指导
会议。我们将协助获奖者制定校外资助提案,包括举办模拟“研究”
与 PDC 合作,以确保提案具有竞争力。对于那些外部应用程序
跌破支付线,我们将返回第一阶段并支持后续的进一步概念开发
应用程序。我们还将确保通过 PPP 进行的所有研究始终符合原则
多样性、公平性和包容性。我们将利用与 CTSA、国务院的现有合作关系
健康、新英格兰北部实践研究网络和农村健康通讯
网络。通过重组我们的试点奖项,我们将支持一系列项目,从多阶段临床
以及针对特定社区公共卫生举措的转化研究。这应该为试点获奖者提供
有机会提升他们的学术生涯,同时满足快速变化的公共卫生需求
我们的社区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH H. NADEAU其他文献
JOSEPH H. NADEAU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH H. NADEAU', 18)}}的其他基金
Master regulators of unexplained variation in disease risk
疾病风险无法解释的变异的主要调节因素
- 批准号:
10492766 - 财政年份:2021
- 资助金额:
$ 53.12万 - 项目类别:
Master regulators of unexplained variation in disease risk
疾病风险无法解释的变异的主要调节因素
- 批准号:
10670982 - 财政年份:2021
- 资助金额:
$ 53.12万 - 项目类别:
Master regulators of unexplained variation in disease risk
疾病风险无法解释的变异的主要调节因素
- 批准号:
10273583 - 财政年份:2021
- 资助金额:
$ 53.12万 - 项目类别:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
Lamarck Redux:跨代遗传对表型和疾病的影响
- 批准号:
8722583 - 财政年份:2010
- 资助金额:
$ 53.12万 - 项目类别:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
Lamarck Redux:跨代遗传对表型和疾病的影响
- 批准号:
8645834 - 财政年份:2010
- 资助金额:
$ 53.12万 - 项目类别:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
Lamarck Redux:跨代遗传对表型和疾病的影响
- 批准号:
8517171 - 财政年份:2010
- 资助金额:
$ 53.12万 - 项目类别:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
Lamarck Redux:跨代遗传对表型和疾病的影响
- 批准号:
8316233 - 财政年份:2010
- 资助金额:
$ 53.12万 - 项目类别:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
Lamarck Redux:跨代遗传对表型和疾病的影响
- 批准号:
8152152 - 财政年份:2010
- 资助金额:
$ 53.12万 - 项目类别:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
Lamarck Redux:跨代遗传对表型和疾病的影响
- 批准号:
7979938 - 财政年份:2010
- 资助金额:
$ 53.12万 - 项目类别:














{{item.name}}会员




